Neurochemical Alterations in Physical Dependence on Butorphanol

  • Ho, I. K. (Department of Pharmacology and Toxicology, University of Mississippi Medical Center) ;
  • Fan, Lir-Wan (Department of Pharmacology and Toxicology, University of Mississippi Medical Center) ;
  • Kim, Seong-Youl (Department of Pharmacology and Toxicology, University of Mississippi Medical Center) ;
  • Ma, Tangeng (Department of Pharmacology and Toxicology, University of Mississippi Medical Center) ;
  • Rockhold, Robin W. (Department of Pharmacology and Toxicology, University of Mississippi Medical Center)
  • Published : 2004.12.01

Abstract

This review focuses on finding neurochemical changes in physical dependence on butorphanol, a relatively potent mixed agonist-antagonist opioid analgesic agent that is five times more potent than morphine in antinociceptive effects. The chronic administration of butorphanol induces physical dependence. Withdrawal from such dependence can be reliably precipitated by administration of a narcotic antagonist, e.g., naloxone. Evidence for critical involvement of excitatory aminoacid (glutamate), opioid receptors, and phosphorylation of proteins in these phenomena is summarized.

Keywords

References

  1. Aghajanian, G. K., Kogan, J. H. and Moghaddam, B. (1994). Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: An in vivo microdialysis study. Brain Res. 636, 126-130 https://doi.org/10.1016/0006-8993(94)90186-4
  2. Brown, G. R. (1985). Stadol dependence: another case. JAMA 254,910 https://doi.org/10.1001/jama.254.7.910
  3. Chang, K. J., Wei, E. T., Kilian, A. and Chang, J. K. (1983). Potent morphiceptin analogs: structure activity relationships and morphine-like activities. J. Pharmacal. Exp. Ther. 227, 403-408
  4. Dobkin, A. B., Arandia, H. Y., Byles, P. H., Africa, B. F, Caruso, F S. and Noveck R. 1. (1976). Butorphanol tartrate: 2. Safety and efficacy in balanced anaesthesia. Can. Anaesth. Soc. J. 23, 601-608 https://doi.org/10.1007/BF03006742
  5. Edgar, P. F, Douglas, J. E., Cooper, G. J., Dean, B., Kydd, R. and Faull, R. L. (2000). Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol. Psychiatry 5, 85-90 https://doi.org/10.1038/sj.mp.4000580
  6. Evans, W. S., Bowen, J. N., Giordano, F. L. and Clark, B. A. (1985). A case of stadol dependence. JAMA. 253,2191-2192 https://doi.org/10.1001/jama.253.15.2191
  7. Fan, L. W, Tanaka, S., Park, Y, Sasaki, K, Ma, T, Tien, L.T, Rockhold, R. W and Ho, I. K (2002a). Butorphanol dependence and withdrawal decrease hippocampal $k_2$-opioidreceptor binding. Brain Res. Bull. 958, 277-290 https://doi.org/10.1016/S0006-8993(02)03572-2
  8. Fan, L. W, Tanaka, S., Tien, L. T., Ma, T, Rockhold, R. W. and Ho, I. K (2002b). Withdrawal from dependence upon butorphanol uniquely increases K"l-opioid receptor binding in the rat brain. Brain Res. Bull. 58, 149-160 https://doi.org/10.1016/S0361-9230(02)00760-8
  9. Fan, L. W, Tien, L. T, Tanaka, S., Ma, T, Chudapongse, N., Sinchaisuk, S., Rockhold, R. W and Ho, I. K (2003a). Changes in the brain K"-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol. Neurosci. 121, 1063-1074 https://doi.org/10.1016/S0306-4522(03)00299-9
  10. Fan, L. W, Tien, T T, Tanaka, S., Sasaki, K, Park, Y, Ma, T, Rockhold, R. Wand Ho, I. K (2003b). Enhanced binding of nor-binaltorphimine to K-opioid receptors in rats dependent on butorphanol. J. Neurosci. Res. 72,781-789 https://doi.org/10.1002/jnr.10578
  11. Feng, Y Z., Rockhold, R. W and Ho, I. K (1997). Norbinaltorphimine precipitates withdrawal and excitatory amino acid release in the locus coeruleus of butorphanol but not morphine-dependent rats. J. Pharmacol. Exp. Ther. 283, 932-938
  12. Feng, Y. Z., Zhang, T, Rockhold, R. W and Ho, I. K (1995). Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat. Neurochem. Res. 20, 745-751 https://doi.org/10.1007/BF01705544
  13. Fisher, M. A. and Glass, S. (1997). Butorphanol (Stadol): a study in problems of current drug information and control. Neurol. 48, 1156-1160 https://doi.org/10.1212/WNL.48.5.1156
  14. Horan, P. and Ho, I. K (1991). The physical dependence liability of butorphanol: A comparative study with morphine. Eur. J. Pharmacol. 203, 387-391 https://doi.org/10.1016/0014-2999(91)90895-W
  15. Hoshi, K, Ma, T, Oh, S. and Ho, I. K (1997). Increased release of excitatory amino acids in rat locus coeruleus in kappaopioid agonist dependent rats precipitated· by norbinaltorphimine. Brain Res. 753, 63-68 https://doi.org/10.1016/S0006-8993(96)01492-8
  16. Jang, C., Park, Y., Rockhold, R.w. and Ho, I. K (1999). Autoradiographic study of NMDA-displaceable [$^3$H]glutamate and [$^3$H] MK-801 binding during butorphanol withdrawal in the rat brain. Brain Res. 845, 236-241 https://doi.org/10.1016/S0006-8993(99)01949-6
  17. Jaw, S. P, Hoskins, B. and Ho, I. K (1993a). Opioid antagonists and butorphanol dependence. Pharmacol. Biochem. Behav. 44, 497-500 https://doi.org/10.1016/0091-3057(93)90158-P
  18. Jaw, S. P, Makimura, M., Hoskins, B. and Ho, I. K (1993b). Effects of nor-binaltorphimine on butorphanol dependence. Eur. J. Pharmacol. 239, 133-140 https://doi.org/10.1016/0014-2999(93)90986-R
  19. Jaw, S. P, Makimura, M., Oh, K W., Hoskins, B. and Ho, I. K (1994). Involvement of K-opioid receptors in opioid dependence/withdrawal: Studies using butorphanol. Eur. J. Pharmacol. 257, 153-160 https://doi.org/10.1016/0014-2999(94)90707-2
  20. Kim, S. Y., Chudapongse, N., Lee, S. M., Levin, M. C., Oh, J. T, Park, H. J. and Ho, I. K (2004). Proteomic analysis of phosphotyrosyl proteins in the rat brain: Effect of butorphanol dependence. J. Neuroscience Res. 77, 867-877 https://doi.org/10.1002/jnr.20214
  21. Lahti, R. A., Mickelson, M. M., McCall, J. M. and Von Voigtlander, P. F. (1985). [$^3$H]U-69593, a highly selective ligand for the opioid kappa receptor. Eur. J. Pharmacol. 109,281-284 https://doi.org/10.1016/0014-2999(85)90431-5
  22. Liu, N., Rockhold, R. Wand Ho, I., K (1999). Electrical stimulation of nucleus paragigantocellularis induces opioid withdrawal-like behaviors in the rats. Pharmacol. Biochem. Behav. 62, 263-271 https://doi.org/10.1016/S0091-3057(98)00164-6
  23. Mamoon, A. M., Bames, A. M., Ho, I. K. and Hoskins, B. (1995). Comparative rewarding properties of morphine and butorphanol. Brain Res. Bull. 38, 507-511 https://doi.org/10.1016/0361-9230(95)02022-J
  24. Peachey, J. E. (1987). Clinical observations of agonist-antagonist analgesic dependence. Drug Alcohol Depend. 20, 347-365 https://doi.org/10.1016/0376-8716(87)90008-1
  25. Pircio, A. W, Bylys, J. A., Cavanagh, R. L., Buyniski, J. P and Bierwagen, M. E. (1976). The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic. Arch. Int. Pharmacodyn. Ther. 220,231-257
  26. Smith, S. G. and Davis, W. M. (1984). Nonmedical use of butorphanol and diphenhydramine. NoiBOLi 252, 1010
  27. Tokuyama, S., Wakabayashi, H. and Ho, I. K (1996). Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur. J. Pharmacol. 295, 123-129 https://doi.org/10.1016/0014-2999(95)00645-1
  28. Wongchanapai, W., Tsang, B. K, He, Z., and Ho, I. K (1998a). Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine. Pharmacol. Biochem. Behav. 60, 899-907 https://doi.org/10.1016/S0091-3057(98)00074-4
  29. Wongchanapai, W., Tsang, B. K, He, Z., Ma, T and Ho, I. K (1998b). Super-sensitivity of spinal opioid receptors to antagonists in intrathecal butorphanol and morphine dependence. Life Sci. 63, 2175-2180
  30. Woods, J. H. and Gmerek, D. E. (1985) Substitution and primary dependence studies in animals. Drug Alcohol Depend. 14, 233-247 https://doi.org/10.1016/0376-8716(85)90059-6
  31. Zhang, T, Feng, Y. Z., Rockhold, R. W and Ho, I. K (1994). Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat. Life Sci. 55, 25-31
  32. Zhu, H., Rockhold, R. W and Ho, I. K (1998). The role of glutamate in physical dependence on opioids. Jpn. J. Pharmacol. 76,1-14 https://doi.org/10.1254/jjp.76.1